Home > News > Nanogen Receives 510(k) Clearance
March 29th, 2006
Nanogen Receives 510(k) Clearance
Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its StatusFirst(TM) CHF NT-proBNP EDTA plasma test to aid in the diagnosis of individuals suspected of having congestive heart failure (CHF).
Source:
prnewswire
Related News Press |
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Announcements
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Finding quantum order in chaos May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||